Pre-Seed Finance Raise of the Year

This award recognises a European life science company that has successfully completed a significant, impactful or transformational private fundraise at pre-seed level.

Seed-Stage Finance Raise of the Year

Series A Finance Raise of the Year

This award recognises a European life science company that has successfully completed a significant, impactful or transformational private fundraise at Series A level.

Series B Finance Raise of the Year

This award recognises a European life science company that has successfully completed a significant, impactful or transformational private fundraise at Series B level.

Series C (and beyond) Finance Raise of the Year

This award recognises a European life science company that has successfully completed a significant, impactful or transformational private fundraise at Series C or beyond level.

IPO of the Year hosted by Kempen

This award recognises a European life science company that has successfully completed a significant, impactful or transformational IPO on any international exchange.

Post-IPO Equity Raise of the Year

This award recognises a European life science company that has successfully completed a significant, impactful or transformational secondary placement or follow-on equity raise (not debt) on any international exchange. CRITERIA AND ENTRY

Debt Finance Raise of the Year

This award recognises a European life science company that has successfully completed a significant, impactful or transformational debt financing.

Venture Capital Firm of the Year

Corporate Venture Firm of the Year

This award recognises a European corporate venture capital firm or strategic investor that has created value for its portfolio, demonstrated truly outstanding investment decision making and outperformed peers.

Deal of the Year (<€500m)

This award recognises European organisations who have executed a truly transformational and high value licensing deal, at a potential deal value of <€500m.

Deal of the Year (>€500m)

This award recognises the teams and organisations who have executed a truly transformational and high value licensing deal., at a potential deal value o

M&A Deal of the Year

This award recognises European organisations who have executed a truly transformational and high value M&A.

Pharma BD Team of the Year

This award recognises a BD team from a pharma or large cap biotech company that has excelled in sourcing, executing and delivering extraordinary and transformational deals that created significant value.

Biotech Company of the Year hosted by MSD

This award recognises a European Biotech (drug discovery, pre-clinical, clinical, OTM therapeutic) company that has demonstrated superior excellence in strategy, process, focus and execution.

Medtech Company of the Year

This award recognises a European Medtech (device, surgical, diagnostic) company that has demonstrated superior excellence in strategy, process, focus and execution. 

Healthtech Company of the Year

This award recognises a European Healthtech (digital health, digital therapeutics, databases, applications and wearables) company that has demonstrated superior excellence in strategy, process, focus and execut

Pharma Company of the Year

This award recognises a European Pharma or large-cap Biotech company that has demonstrated superior excellence in strategy, process, focus and execution and contributed to the broader life science industry.  CRITERIA AND ENTRY

Private Company CEO of the Year

This award recognises a private company CEO that has demonstrated truly outstanding and exemplary leadership in their company and wider industry.

Public Company CEO of the Year

This award recognises a publicly-listed company CEO that has demonstrated truly outstanding and exemplary leadership in their company and wider industry.